Company intelligence / Profile preview

ChironX

Ownership: Private
Employees: ~20
Development stage: Other

Overview

The ChironX platform uses advanced image processing and machine learning to analyze medical images—especially retinal fundus photos—to detect diseases such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, diabetic macular edema, oral cancer, and cervical cancer. It annotates lesions/regions of interest to assist clinicians in diagnosis with high accuracy. The system has been deployed with several hospital partners in India to improve workflow efficiency and reduce preventable blindness.

Therapeutic areas: OphthalmologyOncologyCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

AkhandJyoti Eye HospitalSwarup Eye CentreDrishtiDr Shroff’s Charity Eye HospitalIntuVisionSusrut

Beyond the preview

Go deeper on ChironX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChironX.

Explore the full profile